Multiple Dose Study in Heart Failure of BAY 1067197

NCT02040233 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: BAY1067197 (10 mg)
DRUG: BAY1067197
DRUG: Placebo (10 mg)
DRUG: Placebo

Sponsor

Bayer